THE TAPE
MFC · Life Insurance · $74.4B

Manulife Financial Corp.

$43.69▼ −0.84%
Last close
Relative strength
66RS
of 99, against every stock▼ -9 on the month
Cooling off
Unconfirmed
+7.5%
six months against Life Insurance
52-week range
−5.4%
from the high
$32.58$46.19
Setup
vcpplayed out
+12.8%
against the pivot at $38.72
86 days
Feb 10 · not confirmed
No US GAAP filings to read.
11/16 O 43.98 H 44.16 L 43.55 Vol 1.1M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS66
vs pivot+12.84%
Tightening1.18×
Dry-up1.70×
Up/down vol0.12
From high5%
played out5 of 9checks
Cooling off
Support and resistance
Support below
$41.70
-4.6% · tested 5× · last 32 sessions ago
Resistance above
$44.05
+0.8% · tested 3× · last 13 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 10.0 weeks and fell 16% from its ceiling at its deepest. The pivot is $38.72, and the stock closed 12.8% above that pivot. Its relative strength rating is 66.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against its industry
-3.1%
Three months against its industry
+3.9%
Six months against its industry
+7.5%

Read against an equal-weighted index of Life Insurance, which is +6.1% against the S&P 500 over six months Not aligned.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap
4
days
Ex-dividend in 4 days
Nov 20, 2026 · 1 more dated below
  1. Ex-dividendconfirmedin 4d
    Ex-dividend date
    Nov 20, 2026
  2. Earningstentativein 86d
    Quarterly earnings
    Feb 10, 2027
How it moves on earnings

On average 3.3% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business

No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.

Tracked funds

Held by 2 of 46 tracked funds at the end of Q3 2026.

Last quarter: 1 bought new, 1 added.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-05
above 20d & 50d on 1.7x volume at 45.99
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-03
above 20d & 50d on 1.7x volume at 44.76
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

What lines up

5 of 9 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
Range tightening through the base
Volume drying up through the base
More up-volume than down-volume
Within 15% of its 52-week high
What analysts expect
Strong buy3
Buy6
Hold4
Sell0
Strong sell2

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

Checking your subscription…

X-ray

The most recent of 2 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Manulife Financial Corp. (MFC) — The Tape